Prescriptions Blog: F.D.A. Delays Approval of New Diabetes Drug
Thursday, January 19, 2012 - 17:10
in Health & Medicine
Federal drug regulators are seeking more data from AstraZeneca and Bristol-Myers Squibb before deciding whether to approve dapagliflozin, a new drug aimed at Type 2 diabetes.